دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران
نسخه چاپی

زهرا غریب ناصری

اطلاعات تماس
تلفن: 02162921314
مرتبه علمی
استادیار
دانشکده
هيات علمي پژوهشي
مرکز تحقیقاتی
موسسه ملی تحقیقات سلامت
درباره
آخرین به روزرسانی: 1398/10/25

1.

Pharm D


داروسازی, دانشگاه علوم پزشکی تهران, تهران, ایران, 1389
2.

Ph.D


اقتصاد و مدیریت دارویی, علوم پزشکی تهران, تهران, ایران, 1395
1.

English


صحبت: Good, خواندن: Good, نوشتن: Good
2.

Persian


صحبت: Native, خواندن: Native, نوشتن: Native

Pharm D

1.

اقتصاد و مدیریت دارو


1396-1397 دانشگاه جندی شاپور اهواز، دانشکد,Pharm D.
1.

وضعیت منابع فیزیکی سلامت


Status: Completed, Executers: زهرا غریب ناصری، زهرا گودرزی، علیرضا اولیایی منش, Sponser: مؤسسه ملی تحقیقات سلامت, Location: گروه اقتصاد سلامت, 2017-2018
2.

ارزیابی فناوری سالمت پرگابالين(PREGABALIN) در درمان نوروپاتي و فيبروميالژيا در مقایسه با داروهاي رايج


Status: Completed, Executers: شكوفه نيكفر، امير هاشمي مشکینی،خسرو کشاورز، زهرا غریب ناصری, Sponser: وزارت بهداشت درمان و آموزش پزشکی، دفتر ارزیابی فناوری سلامت, Location: دانشکده داروسازی، دانشگاه علوم پزشکی تهران, 2013-2014
3.

ارزیابی فناوری سالمت اگزمستان(Exemestane) دردرمان سرطان سینه اولیه و پیشرفته در مقایسه با داروهاي رايج


Status: Completed, Executers: شكوفه نيكفر، امير هاشمي مشکینی،خسرو کشاورز، زهرا غریب ناصری, Sponser: وزارت بهداشت درمان و آموزش پزشکی، دفتر ارزیابی فناوری سلامت, Location: دانشکده داروسازی، دانشگاه علوم پزشکی تهران, 2013-2014

Referee

1.

ارائه مدلی جهت توزیع کارآمد خدمات بهداشتی و درمانی با توجه به ملاحظات اقتصادی (مطالعه موردی دستگاه MRI(


سید عطا سرمدی,
M.Sc, MBA- گرایش مدیریت عملیات و زنجیره تأمین, 2018
2.

آنالیز اثربودجه ورود واکسن روتاویروس به برنامه ایمن سازی کشوری ایران


زهرا آزاد,
Pharm D, داروسازی, 1396

راهنما

1.

ارزیابی اقتصادی به کارگیری داروی امیسیزومب (Emicizumab) در مقایسه با داروی فایبا (Feiba) و آریوسون (Aryoseven) در بیماران مبتلا به هموفیلی A مقاوم به فاکتور VIII


فریده ابوالقاسمی,
Pharm D, داروسازی, در حال انجام
2.

بررسی تاثیرات اقتصادی حذف داروهای بدون نسخه از فهرست پوشش بیمه ای


لادن ارمغان,
Pharm D, داروسازی, در حال انجام

Farsi

1.

A practical approach to pharmaceutical policy. World Bank Publications,


Authors: Seiter, Andreas.
Translation

مقالات

English

1.

Economic Analysis of an Ambulatory Care Service Delivery Model for Hemophilia a Patients; A Cost Minimization Study


Authors: Abolfazl Sadeghi, Majid Davari, Zahra Gharibnaseri, Roya Ravanbod, Peyman Eshghi
Journal of Pharmaceutical Research International, Year. 2019,
2.

Health status and quality of life in patients with severe hemophilia A: A cross-sectional survey


Authors: Majid Davari, Zahra Gharibnaseri, Roya Ravanbod, Abolfazl Sadeghi
Hematology Reports, Vol.11, No.2, Year. 2019,
3.

Safety And Effectiveness of Insulin Analogues Versus Human Insulin In Type 2 Diabetes; A Systematic Review And Meta-Analysis


Authors: M Davari, B Amani, Z Gharibnaseri, M Dehghani, H Zakeri, E Khorasani, M Varmaghani
Value in Health, Vol.20, No.9, Year. 2017,
4.

Cost-Utility of Prophylaxis VS. On-Demand Treatment In Severe Haemophilia A Patients


Authors: Z Gharibnaseri, M Davari, A Cheraghali, P Eshghi, R Ravanbod, R Spendar, J Khedmati
Value in Health, Vol.19, No.7, Year. 2016,
5.

A Patient Level Simulation Model


Authors: Z Gharibnaseri, M Davari, A Cheraghali, P Eshghi, R Ravanbod, R Spendar
Value in Health, Vol.19, No.7, Year. 2016,
6.

Health care resource utilization and cost of care for haemophilia A and B patients in Iran


Authors: Zahra Gharibnaseri, Majid Davari, Abdolmajid Cheraghali, Peyman Eshghi, Roya Ravanbod, Ramin Espandar, Razieh Hantooshzadeh
Transfusion and Apheresis Science, Vol.54, No.1, Year. 2016,
7.

Cost-effectiveness analysis of cinacalcet versus vitamin D analogs in secondary hyperparathyroidism in end-stage renal disease patients on dialysis (Protocol)


Authors: Nilofar Sharahi, Majid Davari, Tahereh Malakoutian, Zahra Gharibnaseri
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol.2, No.1/2, Year. 2016,
8.

Prior authorization by the Health Insurance Organizations in Iran


Authors: Mehrnaz Kheirandish, Zahra Gharibnaseri, Fatemeh Soleymani, Abbas Kebriaeezadeh
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol.1, No.3/4, Year. 2015,
9.

The effectiveness of cinacalcet for SHPT in ESRD patients on dialysis


Authors: Nilofar Sharahi, Majid Davari, Zahra Gharibnaseri, Tahereh Malakoutian, Mohsen Shati
PROSPERO International prospective register of systematic reviews, Year. 2015,
10.

Geographical distribution of pharmacies in two provincial capitals in Iran


Authors: Zahra Gharibnasri, Mehrnaz Kheirandish, Bahram Delfan, Abbas Kebriaeezadeh
Pharmacoeconomics and Pharmaceutical Management, Vol.1, No.2, Year. 2015,
11.

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience


Authors: Khosro Keshavarz, Amir Hashemi-Meshkini, Zahra Gharibnaseri, Shekoufeh Nikfar, Abbas Kebriaeezadeh, Mohammad Abdollahi
Archives of medical science: AMS, Vol.9, No.6, Year. 2013,
12.

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies


Authors: Mohammad Ali Rezvanfar, Abbas Kebriaeezadeh, Mostafa Moein, Shekoufeh Nikfar, Zahra Gharibnaseri, Akbar Abdollahi-Asl
Journal of research in pharmacy practice, Vol.2, No.4, Year. 2013,
13.

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer


Authors: Amir Hashemi-Meshkini, Khosro Keshavarz, Zahra Gharibnaseri, Mehrnaz Kheirandish, Abbas Kebriaeezadeh, Shekoufeh Nikfar, Mohammad Abdollahi
Archives of medical science: AMS, Vol.9, No.3, Year. 2013,
14.

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children


Authors: Zahra Gharibnaseri, Abbas Kebriaeezadeh, Shekoufeh Nikfar, Gholamreza Zamani, Akbar Abdollahiasl
DARU Journal of Pharmaceutical Sciences, Vol.20, No.1, Year. 2012,
15.

OLD AND NEW ANTIEPILEPTIC DRUGS UTILIZATION IN IRAN


Authors: Z Gharibnaseri, M Kheirandish, A Kebriaeezadeh
Value in Health, Vol.15, No.7, Year. 2012,
16.

Geographical distribution of pharmacies versus population: The case of two capital cities in Iran


Authors: M Kheirandish, Z Gharibnaseri, A Kebriaeezadeh
Value in Health, Vol.15, No.7, Year. 2012,
17.

Cost Analysis of Childhood Asthma in Iran: A Cost Evaluation Based on Referral Center Data for Asthma & Allergies


Authors: MA Rezvanfar, A Kebriaeezadeh, M Moein, S Nikfar, Z Gharibnaseri, A Abdollahi-Asl
Value in Health, Vol.15, No.7, Year. 2012,
18.

The Effectiveness and Cost-effectiveness of Pregabalin in the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Economic Model


Authors: Amir Hashemi Meshkini, Khosro Keshavarz, Zahra Gharibnaseri, Shekoufeh Nikfar, Mohammad Abdollahi
International Journal of Pharmacology, Year. 2012,
19.

Ileal relaxation induced by Mentha longifolia (L.) leaf extract in rat


Authors: MK Naseri, Zahra Gharib Naseri, Maryam Mohammadian, Marzie Omidi Birgani
Pak J Biol Sci, Vol.11, No.12, Year. 2008,
20.

Antispasmodic effect of Physalis alkekengi fruit extract on rat uterus


Authors: Mohammad Kazem Gharib Naseri, Maryam Mohammadi, Zahra Gharibnaseri
Iranian Journal of Reproductive Medicine, Vol.6, No.4, Year. 2008,
21.

Antispasmodic Effect of Glycyrrhiza Glabra Leaf on Rat Ileum Contractions


Authors: Mohammad Kazem Gharibnaseri, Maedeh Arabian, Zahra Gharibnaseri
Shahrekord University of Medical Sciences Journal, Vol.9, No.3, Year. 2007,

ارائه ها و خلاصه ها

Farsi

1.

Cost-Effectiveness analysis of cinacalcet for Secondary hyperparathyroidism in end stage renal disease patients on dialysis


14th Iranian Pharmaceutical Sciences Congress and 1st Symposium of Biopharmaceutics and Pharmacokinetics
2015Type : پوستر, Lecturer,
2.

Cost-Effectiveness of Prophylaxis vs. On-Demand


6th National Seminar of Haemophilia and Other Coagulopathies
2016Type : سخنرانی, Lecturer,
3.

Future of Pharmaceutical Industry in Iran and Worldwide


Location: Tehran,
2013Type : سخنرانی, Lecturer,

English

1.

Utilization trend of anti-diabetic agents in Iran (2005-2009)


Middle East Diabetes Economics-MEDEC
Location: Kish Island,
2011Type : سخنرانی, Lecturer,
1.

HTA in Action


Editor,

Health technology assessment in action is a peer- review journal which is publishing all articles related to health technology assessment. This scientific journal is founded by the National Institute for Health Research. The Journal context is dedicated to papers about reviewing aspects of safety, effectiveness and economic evaluation of medical equipment, medicines, vaccines, procedures, and systems developed to solve a health problem as well as articles related to policy recommendations, horizon scanning and etc.

1.

International Society of Pharmacoeconomics and Outcomes Research (ISPOR)


Activity Type:Member
2014
2.

Medical Council of the Islamic Republic of Iran (IRIMC)


Activity Type:Member
2010
Top